Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effects of cluster-set resistance training on mental health and sleep quality in sedentary young women: protocol for a randomized controlled trial.

Frontiers in psychology·2026
Same author

Assembly of Protein-DNA Framework Nanostructures: Structurally Defining Protein-DNA Interfaces With Aptamer.

Angewandte Chemie (International ed. in English)·2026
Same author

Uric acid promotes dietary lipid absorption through microbiome and metabolomic remodeling via a liver-gut endocrine axis.

Cell host & microbe·2026
Same author

YY1 Lactylation Elicits CARD9 Deficiency in Dendritic Cells Promoting Pancreatic Cancer Immune Escape.

International journal of biological sciences·2026
Same author

Baicalein suppresses mitochondrial biogenesis via the RBM43/PGC-1α axis in triple-negative breast cancer cells.

Tissue & cell·2026
Same author

Prognostic value of androgen receptor expression in ER-positive/HER2-negative breast cancer: evidence from a contemporary Chinese cohort.

Frontiers in oncology·2026

Related Experiment Video

Updated: May 14, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.0K

SIRT1: Harnessing multiple pathways to hinder NAFLD.

Cheng Tian1, Rongrong Huang2, Ming Xiang1

  • 1Department of Pharmacology, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

Pharmacological Research
|March 25, 2024
PubMed
Summary

Sirtuin 1 (SIRT1) plays a crucial role in non-alcoholic fatty liver disease (NAFLD). Activating SIRT1 shows promise for developing new NAFLD therapies by targeting key disease mechanisms.

Keywords:
AutophagyLipid metabolismMitochondriaNAFLDOxidative stressSIRT1

More Related Videos

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.3K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

883

Related Experiment Videos

Last Updated: May 14, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.0K
A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
08:35

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

6.3K
Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

883

Area of Science:

  • Hepatology
  • Molecular Biology
  • Biochemistry

Background:

  • Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver conditions with no approved treatments.
  • Sirtuin 1 (SIRT1) is increasingly recognized for its significant association with NAFLD pathogenesis.
  • Understanding SIRT1's role is vital for developing effective NAFLD therapies.

Purpose of the Study:

  • To review the structure and function of SIRT1.
  • To summarize the impact of SIRT1 on NAFLD.
  • To explore the therapeutic potential of SIRT1 agonists for NAFLD.

Main Methods:

  • Literature review of studies investigating SIRT1 and NAFLD.
  • Analysis of mechanisms by which SIRT1 influences NAFLD progression.
  • Examination of therapeutic agents targeting SIRT1.

Main Results:

  • SIRT1 activation or overexpression ameliorates NAFLD, while deficiency exacerbates it.
  • Various agents, including natural compounds and stem cells, alleviate NAFLD through SIRT1 modulation.
  • SIRT1 mechanisms include regulating autophagy, mitochondrial function, oxidative stress, lipid metabolism, apoptosis, and inflammation.

Conclusions:

  • SIRT1 is a key regulator in NAFLD.
  • Targeting SIRT1 offers a promising therapeutic strategy for NAFLD.
  • Further research into SIRT1 agonists is warranted for NAFLD treatment.